The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chondroitin Market Research Report 2025
Synopsis
Chondroitin is a chondrin derivative, generally is Chondroitin sulfate.
Chondroitin sulfate is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars (N-acetylgalactosamine and glucuronic acid). It is usually found attached to proteins as part of a proteoglycan. A chondroitin chain can have over 100 individual sugars, each of which can be sulfated in variable positions and quantities. Chondroitin sulfate is an important structural component of cartilage and provides much of its resistance to compression. Along with glucosamine, chondroitin sulfate has become a widely used dietary supplement for treatment of osteoarthritis.
The global Chondroitin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Global Chondroitin Sulfate key players include SANXIN, WanTuMing Biological, TSI Group, Yantai Dongcheng, Focus Chem, etc. Global top five manufacturers hold a share over 25%.
China is the largest market, with a share over 75%, followed by Europe and North America, both have a share over 10%.
In terms of product, Food Grade is the largest segment, with a share over 70%.
This report aims to provide a comprehensive presentation of the global market for Chondroitin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chondroitin.
Report Scope
The Chondroitin market size, estimations, and forecasts are provided in terms of sales volume (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chondroitin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chondroitin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
SANXIN
Focus Chem
GGI
Guanglong Biochem
Hengjie Bio-Pharmaceuticals
Huiwen
ISBA
Jiaixng Hengjie
Meitek
Nippon Zoki
Pacific Rainbow
Qingdao Green-Extract
QJBCHINA
Runxin Biotechnology
SANXIN GROUP
Shandong Dongcheng
Sioux Pharm
Summit Nutritionals
TSI Group
WanTuMing Biological
Yantai Dongcheng
YBCC
Yibao Group
Segment by Type
Food Grade
Pharmaceutical Grade
Segment by Application
Pharmacy
Health Products
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chondroitin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chondroitin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Chondroitin is a chondrin derivative, generally is Chondroitin sulfate.
Chondroitin sulfate is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars (N-acetylgalactosamine and glucuronic acid). It is usually found attached to proteins as part of a proteoglycan. A chondroitin chain can have over 100 individual sugars, each of which can be sulfated in variable positions and quantities. Chondroitin sulfate is an important structural component of cartilage and provides much of its resistance to compression. Along with glucosamine, chondroitin sulfate has become a widely used dietary supplement for treatment of osteoarthritis.
The global Chondroitin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Global Chondroitin Sulfate key players include SANXIN, WanTuMing Biological, TSI Group, Yantai Dongcheng, Focus Chem, etc. Global top five manufacturers hold a share over 25%.
China is the largest market, with a share over 75%, followed by Europe and North America, both have a share over 10%.
In terms of product, Food Grade is the largest segment, with a share over 70%.
This report aims to provide a comprehensive presentation of the global market for Chondroitin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chondroitin.
Report Scope
The Chondroitin market size, estimations, and forecasts are provided in terms of sales volume (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chondroitin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chondroitin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
SANXIN
Focus Chem
GGI
Guanglong Biochem
Hengjie Bio-Pharmaceuticals
Huiwen
ISBA
Jiaixng Hengjie
Meitek
Nippon Zoki
Pacific Rainbow
Qingdao Green-Extract
QJBCHINA
Runxin Biotechnology
SANXIN GROUP
Shandong Dongcheng
Sioux Pharm
Summit Nutritionals
TSI Group
WanTuMing Biological
Yantai Dongcheng
YBCC
Yibao Group
Segment by Type
Food Grade
Pharmaceutical Grade
Segment by Application
Pharmacy
Health Products
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chondroitin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chondroitin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Chondroitin Market Overview
1.1 Product Overview and Scope of Chondroitin
1.2 Chondroitin Segment by Type
1.2.1 Global Chondroitin Market Value Comparison by Type (2024-2030)
1.2.2 Food Grade
1.2.3 Pharmaceutical Grade
1.3 Chondroitin Segment by Application
1.3.1 Global Chondroitin Market Value by Application: (2024-2030)
1.3.2 Pharmacy
1.3.3 Health Products
1.4 Global Chondroitin Market Size Estimates and Forecasts
1.4.1 Global Chondroitin Revenue 2019-2030
1.4.2 Global Chondroitin Sales 2019-2030
1.4.3 Global Chondroitin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Chondroitin Market Competition by Manufacturers
2.1 Global Chondroitin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Chondroitin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Chondroitin Average Price by Manufacturers (2019-2024)
2.4 Global Chondroitin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chondroitin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chondroitin, Product Type & Application
2.7 Chondroitin Market Competitive Situation and Trends
2.7.1 Chondroitin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chondroitin Players Market Share by Revenue
2.7.3 Global Chondroitin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chondroitin Retrospective Market Scenario by Region
3.1 Global Chondroitin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Chondroitin Global Chondroitin Sales by Region: 2019-2030
3.2.1 Global Chondroitin Sales by Region: 2019-2024
3.2.2 Global Chondroitin Sales by Region: 2025-2030
3.3 Global Chondroitin Global Chondroitin Revenue by Region: 2019-2030
3.3.1 Global Chondroitin Revenue by Region: 2019-2024
3.3.2 Global Chondroitin Revenue by Region: 2025-2030
3.4 North America Chondroitin Market Facts & Figures by Country
3.4.1 North America Chondroitin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Chondroitin Sales by Country (2019-2030)
3.4.3 North America Chondroitin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Chondroitin Market Facts & Figures by Country
3.5.1 Europe Chondroitin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Chondroitin Sales by Country (2019-2030)
3.5.3 Europe Chondroitin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chondroitin Market Facts & Figures by Country
3.6.1 Asia Pacific Chondroitin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Chondroitin Sales by Country (2019-2030)
3.6.3 Asia Pacific Chondroitin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Chondroitin Market Facts & Figures by Country
3.7.1 Latin America Chondroitin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Chondroitin Sales by Country (2019-2030)
3.7.3 Latin America Chondroitin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chondroitin Market Facts & Figures by Country
3.8.1 Middle East and Africa Chondroitin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Chondroitin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Chondroitin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chondroitin Sales by Type (2019-2030)
4.1.1 Global Chondroitin Sales by Type (2019-2024)
4.1.2 Global Chondroitin Sales by Type (2025-2030)
4.1.3 Global Chondroitin Sales Market Share by Type (2019-2030)
4.2 Global Chondroitin Revenue by Type (2019-2030)
4.2.1 Global Chondroitin Revenue by Type (2019-2024)
4.2.2 Global Chondroitin Revenue by Type (2025-2030)
4.2.3 Global Chondroitin Revenue Market Share by Type (2019-2030)
4.3 Global Chondroitin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Chondroitin Sales by Application (2019-2030)
5.1.1 Global Chondroitin Sales by Application (2019-2024)
5.1.2 Global Chondroitin Sales by Application (2025-2030)
5.1.3 Global Chondroitin Sales Market Share by Application (2019-2030)
5.2 Global Chondroitin Revenue by Application (2019-2030)
5.2.1 Global Chondroitin Revenue by Application (2019-2024)
5.2.2 Global Chondroitin Revenue by Application (2025-2030)
5.2.3 Global Chondroitin Revenue Market Share by Application (2019-2030)
5.3 Global Chondroitin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 SANXIN
6.1.1 SANXIN Corporation Information
6.1.2 SANXIN Description and Business Overview
6.1.3 SANXIN Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 SANXIN Chondroitin Product Portfolio
6.1.5 SANXIN Recent Developments/Updates
6.2 Focus Chem
6.2.1 Focus Chem Corporation Information
6.2.2 Focus Chem Description and Business Overview
6.2.3 Focus Chem Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Focus Chem Chondroitin Product Portfolio
6.2.5 Focus Chem Recent Developments/Updates
6.3 GGI
6.3.1 GGI Corporation Information
6.3.2 GGI Description and Business Overview
6.3.3 GGI Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GGI Chondroitin Product Portfolio
6.3.5 GGI Recent Developments/Updates
6.4 Guanglong Biochem
6.4.1 Guanglong Biochem Corporation Information
6.4.2 Guanglong Biochem Description and Business Overview
6.4.3 Guanglong Biochem Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guanglong Biochem Chondroitin Product Portfolio
6.4.5 Guanglong Biochem Recent Developments/Updates
6.5 Hengjie Bio-Pharmaceuticals
6.5.1 Hengjie Bio-Pharmaceuticals Corporation Information
6.5.2 Hengjie Bio-Pharmaceuticals Description and Business Overview
6.5.3 Hengjie Bio-Pharmaceuticals Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hengjie Bio-Pharmaceuticals Chondroitin Product Portfolio
6.5.5 Hengjie Bio-Pharmaceuticals Recent Developments/Updates
6.6 Huiwen
6.6.1 Huiwen Corporation Information
6.6.2 Huiwen Description and Business Overview
6.6.3 Huiwen Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Huiwen Chondroitin Product Portfolio
6.6.5 Huiwen Recent Developments/Updates
6.7 ISBA
6.6.1 ISBA Corporation Information
6.6.2 ISBA Description and Business Overview
6.6.3 ISBA Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ISBA Chondroitin Product Portfolio
6.7.5 ISBA Recent Developments/Updates
6.8 Jiaixng Hengjie
6.8.1 Jiaixng Hengjie Corporation Information
6.8.2 Jiaixng Hengjie Description and Business Overview
6.8.3 Jiaixng Hengjie Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Jiaixng Hengjie Chondroitin Product Portfolio
6.8.5 Jiaixng Hengjie Recent Developments/Updates
6.9 Meitek
6.9.1 Meitek Corporation Information
6.9.2 Meitek Description and Business Overview
6.9.3 Meitek Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Meitek Chondroitin Product Portfolio
6.9.5 Meitek Recent Developments/Updates
6.10 Nippon Zoki
6.10.1 Nippon Zoki Corporation Information
6.10.2 Nippon Zoki Description and Business Overview
6.10.3 Nippon Zoki Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nippon Zoki Chondroitin Product Portfolio
6.10.5 Nippon Zoki Recent Developments/Updates
6.11 Pacific Rainbow
6.11.1 Pacific Rainbow Corporation Information
6.11.2 Pacific Rainbow Chondroitin Description and Business Overview
6.11.3 Pacific Rainbow Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Pacific Rainbow Chondroitin Product Portfolio
6.11.5 Pacific Rainbow Recent Developments/Updates
6.12 Qingdao Green-Extract
6.12.1 Qingdao Green-Extract Corporation Information
6.12.2 Qingdao Green-Extract Chondroitin Description and Business Overview
6.12.3 Qingdao Green-Extract Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Qingdao Green-Extract Chondroitin Product Portfolio
6.12.5 Qingdao Green-Extract Recent Developments/Updates
6.13 QJBCHINA
6.13.1 QJBCHINA Corporation Information
6.13.2 QJBCHINA Chondroitin Description and Business Overview
6.13.3 QJBCHINA Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 QJBCHINA Chondroitin Product Portfolio
6.13.5 QJBCHINA Recent Developments/Updates
6.14 Runxin Biotechnology
6.14.1 Runxin Biotechnology Corporation Information
6.14.2 Runxin Biotechnology Chondroitin Description and Business Overview
6.14.3 Runxin Biotechnology Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Runxin Biotechnology Chondroitin Product Portfolio
6.14.5 Runxin Biotechnology Recent Developments/Updates
6.15 SANXIN GROUP
6.15.1 SANXIN GROUP Corporation Information
6.15.2 SANXIN GROUP Chondroitin Description and Business Overview
6.15.3 SANXIN GROUP Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.15.4 SANXIN GROUP Chondroitin Product Portfolio
6.15.5 SANXIN GROUP Recent Developments/Updates
6.16 Shandong Dongcheng
6.16.1 Shandong Dongcheng Corporation Information
6.16.2 Shandong Dongcheng Chondroitin Description and Business Overview
6.16.3 Shandong Dongcheng Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Shandong Dongcheng Chondroitin Product Portfolio
6.16.5 Shandong Dongcheng Recent Developments/Updates
6.17 Sioux Pharm
6.17.1 Sioux Pharm Corporation Information
6.17.2 Sioux Pharm Chondroitin Description and Business Overview
6.17.3 Sioux Pharm Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Sioux Pharm Chondroitin Product Portfolio
6.17.5 Sioux Pharm Recent Developments/Updates
6.18 Summit Nutritionals
6.18.1 Summit Nutritionals Corporation Information
6.18.2 Summit Nutritionals Chondroitin Description and Business Overview
6.18.3 Summit Nutritionals Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Summit Nutritionals Chondroitin Product Portfolio
6.18.5 Summit Nutritionals Recent Developments/Updates
6.19 TSI Group
6.19.1 TSI Group Corporation Information
6.19.2 TSI Group Chondroitin Description and Business Overview
6.19.3 TSI Group Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.19.4 TSI Group Chondroitin Product Portfolio
6.19.5 TSI Group Recent Developments/Updates
6.20 WanTuMing Biological
6.20.1 WanTuMing Biological Corporation Information
6.20.2 WanTuMing Biological Chondroitin Description and Business Overview
6.20.3 WanTuMing Biological Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.20.4 WanTuMing Biological Chondroitin Product Portfolio
6.20.5 WanTuMing Biological Recent Developments/Updates
6.21 Yantai Dongcheng
6.21.1 Yantai Dongcheng Corporation Information
6.21.2 Yantai Dongcheng Chondroitin Description and Business Overview
6.21.3 Yantai Dongcheng Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Yantai Dongcheng Chondroitin Product Portfolio
6.21.5 Yantai Dongcheng Recent Developments/Updates
6.22 YBCC
6.22.1 YBCC Corporation Information
6.22.2 YBCC Chondroitin Description and Business Overview
6.22.3 YBCC Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.22.4 YBCC Chondroitin Product Portfolio
6.22.5 YBCC Recent Developments/Updates
6.23 Yibao Group
6.23.1 Yibao Group Corporation Information
6.23.2 Yibao Group Chondroitin Description and Business Overview
6.23.3 Yibao Group Chondroitin Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Yibao Group Chondroitin Product Portfolio
6.23.5 Yibao Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chondroitin Industry Chain Analysis
7.2 Chondroitin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chondroitin Production Mode & Process
7.4 Chondroitin Sales and Marketing
7.4.1 Chondroitin Sales Channels
7.4.2 Chondroitin Distributors
7.5 Chondroitin Customers
8 Chondroitin Market Dynamics
8.1 Chondroitin Industry Trends
8.2 Chondroitin Market Drivers
8.3 Chondroitin Market Challenges
8.4 Chondroitin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
